In rectal cancer patients treated with surgery alone, a higher density of total and CD8+ T cells in the central tumour and invasive margin is associated with improved disease-free and overall survival [17], and in neoadjuvantly-treated rectal cancer, a greater pre-treatment CD8+ T cell infiltrate predicts good response to CRT [17–19]. This evidence concerns the gene CD8A and neoplasm.